Ocugen Inc - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers section on Ocugen Inc. The assessment of Ocugen Inc is assembled by All Street Sevva using proprietary artificial intelligence. This page is a free ESG report covering Ocugen Inc.
Ocugen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.8.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | Ocugen Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ocugen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ocugen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ocugen Inc report the average age of the workforce?
Sign up for free to unlockDoes Ocugen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ocugen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ocugen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ocugen Inc offer flexible work?
Sign up for free to unlockDoes Ocugen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ocugen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ocugen Inc conduct supply chain audits?
Sign up for free to unlockDoes Ocugen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ocugen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ocugen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ocugen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ocugen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ocugen Inc disclose water use targets?
Sign up for free to unlockDoes Ocugen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ocugen Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ocugen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ocugen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ocugen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ocugen Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ocugen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ocugen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ocugen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ocugen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ocugen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ocugen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ocugen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ocugen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ocugen Inc disclose its waste policy?
Sign up for free to unlockDoes Ocugen Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ocugen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ocugen Inc disclose energy use targets?
Sign up for free to unlockDoes Ocugen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ocugen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ocugen Inc
These potential risks are based on the size, segment and geographies of the company.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.